Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Identifying and Incorporating into Practice Screening Tools for People with HIV who are Aging in the Ryan White HIV/AIDS Program
This HRSA HIV/AIDS Bureau national webinar featured two Ryan White HIV/AIDS Program (RWHAP) providers.
Resource updated 06/09/2022
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic
Recap of changes made in telehealth laws, regulations, and policies and corresponding efforts of healthcare systems, payers, and providers to modify their services to keep clients with HIV engaged in care provided by HRSA's Ryan White HIV/AIDS Program.Resource updated 06/09/2022
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
Fillable CY 2022 – 2026 CDC DHP and HRSA HAB Integrated Prevention and Care Plan Guidance Checklist
Checklist required in the submission of the Integrated Plans for 2022-2026.Resource updated 09/19/2023
-
Crosswalk of the Integrated HIV Prevention and Care Plan Guidance (CY 2016-2021 and CY 2022-2026) and the Ending the HIV Epidemic in the U.S. Program Guidance
Crosswalk of the required components of the 2022-2026 Integrated HIV Prevention and Care Plan with the 2016-2021 Integrated HIV Prevention and Care Plans and the EHE Planning Program Guidance.Resource updated 09/19/2023
-
HIV 101: Fundamentals of HIV Pathogenesis, Antiretroviral Therapy Initiation, & Primary Care for PWH
Session for clinicians new to the field of HIV or those looking for a review on the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
HIV/AIDS Bureau Updates for the 2021 RWHAP Clinical Conference
Summary includes status of national strategic plans, 2022 Ryan White Conference on HIV Care and Treatment, COVID updates (provider burnout), data updates on the RWHAP, new technical assistance resources (e.g., Best Practices Compilation), and EHE activities.Resource (Conference Presentation) updated 09/14/2023
-
Integrated HIV Prevention and Care Plan: Planning Requirements
Outline of the planning requirements for RWHAP Parts A and B recipients and all DHAP-funded state and local health departments as described in the Integrated HIV Prevention and Care Plan Guidance, Including the SCSN, CY 2022-2026.Resource updated 08/03/2023
-
ADR In Focus: Partial Premiums
Full versus partial premiums for ADR client-level data reporting and reporting strategies.Resource updated 09/14/2023
-
Moving Beyond Data Completeness: Ensuring RSR Data Reflect Services Being Provided
Review of 2021 RSR data and data quality issues.Resource updated 12/21/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Reflections on Black Women with HIV and Incarceration
Coming Home: Women, Race, Social Justice & HIV, a virtual learning experience that centered voices from the community of justice-involved Black women with HIV.Blog updated 11/29/2022
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
FY23 RWHAP Part A Non-Competing Continuation Progress Report
FY2023 Ryan White HIV/AIDS Program (RWHAP) Part A Non-Competing Continuation Progress Report.Resource updated 09/19/2023
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022